Taiwan Opens New Center For Phase I, II Drug Trials
This article was originally published in PharmAsia News
Taiwan has opened a university hospital center dedicated to conducting early-stage clinical trials of drugs, with an emphasis on cancer treatments. The National Health Research institutes and the National Cheng Kung University Hospital formed the project to conduct Phase I and Phase II trials. Taiwanese and foreign pharmaceutical companies together already have commissioned the center to conduct trials on about 40 cancer drugs they want to test, about one-fifth of them from local firms. (Click here for more
You may also be interested in...
Amarin had argued that Vascepa’s sales success showed that its patents were not obvious, but the court found otherwise, even as it concluded that Hikma, Dr. Reddy's and West-Ward has infringed on the fish oil pill's patents.
FTC pursuing bogus health and other products or services capitalizing on Covid-19 fear with scams skyrocketing. However, FTC says its enforcement will consider whether businesses are making good faith efforts to produce products in high demand.
Warning letters show FDA's coronavirus investigations inthe consumer health marketplace didn't stop when it suspended facility inspections. The letters identify firms that previously marketed only bedding products as offering supplements with coronavirus claims or that are in other countries and are shipping to US consumers products promoted with coronavirus claims.